← Back to Clinical Trials
Recruiting NCT03908463

NCT03908463 KOMATE Registry: Korean Multicenter Angioplasty Team

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03908463
Status Recruiting
Phase
Sponsor Yonsei University
Condition Coronary Artery Disease
Study Type OBSERVATIONAL
Enrollment 20,000 participants
Start Date 2018-10-05
Primary Completion 2039-04

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Percutaneous coronary intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20,000 participants in total. It began in 2018-10-05 with a primary completion date of 2039-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators will enroll the patients who underwent PCI and was based on real world clinical practice to collect the data regarding demographic, clinical, procedural information and clinical outcome using case report forms.

Eligibility Criteria

Inclusion Criteria: * 1\. Patients older than 19 years * 2\. Patients who undergo percutaneous coronary intervention Exclusion Criteria: * 1\. Refuse to participate * 2\. Pregnant women or women with potential childbearing

Frequently Asked Questions

Who can join the NCT03908463 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03908463 currently recruiting?

Yes, NCT03908463 is actively recruiting participants. Visit ClinicalTrials.gov or contact Yonsei University to inquire about joining.

Where is the NCT03908463 trial being conducted?

This trial is being conducted at Seoul, South Korea.

Who is sponsoring the NCT03908463 clinical trial?

NCT03908463 is sponsored by Yonsei University. The trial plans to enroll 20,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology